| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |